Company Overview of Needham & Company, LLC
Needham & Company, LLC is a boutique investment banking firm. The firm’s principal activities involve advisory and transaction-related services, with a specific focus on public and private financings, mergers, acquisitions and divestitures, equity research and institutional sales and trading. Its strategic advisory services cover mergers and acquisitions, divestitures and exclusive sales, fairness opinions, joint ventures, restructuring, leveraged buyouts and privatizations, spin-off and equity carve-out, takeover defense, and valuation advisory services. Additionally, it provides growth capital, acquisition financing, recapitalization, shareholder liquidity, and corporate and venture servic...
445 Park Avenue
New York, NY 10022
Founded in 1985
Key Executives for Needham & Company, LLC
Chief Executive Officer and President
Managing Director and Co-Founder
Managing Director and Chief Financial Officer
Compensation as of Fiscal Year 2017.
Needham & Company, LLC Key Developments
Needham & Company, LLC Presents at 10th Annual Biotech Showcase 2018, Jan-09-2018 09:00 AM
Dec 28 17
Needham & Company, LLC Presents at 10th Annual Biotech Showcase 2018, Jan-09-2018 09:00 AM. Venue: Hilton San Francisco Union Square, 333 O'Farrell Street, San Francisco, California, United States. Speakers: Alan Carr, Senior Analyst, Biotechnology.
Needham & Company Announces Executive Appointments
Mar 12 17
Needham & Company has reported the addition of key research, sales and sales trading professionals in Health Care Services Research; Boston Equity Sales; Corporate Access Origination & Client Strategy; Event-Driven, Special Situations & Merger Arbitrage Sales; and Sales Trading. Kevin Caliendo, Managing Director, recently joined the Firm. He brings 20 years of Wall Street experience, primarily on the buy-side, analyzing and investing in the health care industry. Kevin spent the past two years at Deimos Asset Management as a portfolio manager. Prior to that, Kevin was a health care portfolio manager at SAC Capital, FrontPoint Partners, and Clearbridge Advisors. Patrick Malloy, Managing Director, has joined to lead the Boston equity sales effort. Pat spent the past seven years at UBS as a senior producer, and nearly four years previously at Cowen and Company. Prior to that, Pat spent two years as an equities trader at Longwood Investments. Erika Olsen, Principal, recently joined to lead the Firm's Corporate Access efforts. Erika has nearly a decade of corporate access experience at Sterne Agee CRT, Open Exchange, Barclays, and Goldman Sachs. Ryan Vaughan, Principal, joined the Firm as a Senior Analyst focusing on event-driven, special situations, distressed & post-reorganization equities. Recently, Ryan was at Third Avenue Management, and spent most of his career at Lombard Odier Asset Management. While at Lombard Odier, Ryan invested across the capital structure, focusing on the Media, Telecom, Consumer, Energy, Industrials & Power sectors. Prior to Lombard Odier, Ryan was a senior analyst in event-driven, special situations, distressed & post-reorganization equities at 3V Capital and Libertas Partners in Greenwich, CT. Greg Seaman, Vice President, recently joined the Firm from Jefferies, where he provided sales trading coverage for a diverse set of clients in the New York and Connecticut regions. Prior to Jefferies, Greg spent five years as a sales trader for CapRok Capital, where he worked primarily on structured debt products. Kevin Caliendo is based in New York and reports to Tom Maloney, Managing Director & Director of Research. Pat Malloy, based in Boston, and Erika Olsen, Ryan Vaughan and Greg Seaman, based in New York, report to Greg Giannakopoulos, Managing Director, Head of Institutional Sales & Sales Trading.
Needham & Company, LLC Announces Executive Appointments
Apr 18 16
Needham & Company, LLC announced the addition of several key sales, trading and capital markets professionals, highlighting the Firm’s commitment to growing a differentiated institutional equities franchise. Greg Giannakopoulos recently joined the Firm as Head of Institutional Sales and is a member of the Firm’s Operating and Commitment Committees. Greg is responsible for leading the delivery of Needham’s research, corporate access, and investment banking services to the Firm’s institutional clients. Greg brings 16 years of capital markets and equity sales production and leadership experience from Raymond James and Deutsche Bank. Eric Ritter joins the Firm as a Managing Director in Institutional Sales and will be responsible for growing the Firm’s institutional relationships with hedge funds domestically with a focus on New York and Connecticut. Eric brings 15 years of capital markets and institutional sales experience to the Firm and joins from Deutsche Bank, where he was most recently responsible for leading the firm’s middle markets sales effort domestically. Frank Hourigan joins the Firm as a Principal in Institutional Sales, and will be responsible for growing the Firm’s institutional client relationships in New York and in various regions domestically. Frank brings 18 years of industry and institutional sales experience to the Firm and joins from Sanford C. Bernstein & Co., where he spent eight years covering buy side institutions across the country. David Newcomb joins the Firm as a Principal and Institutional Healthcare Sector Sales Specialist. David will be responsible for growing the Firm’s institutional client relationships with healthcare and life sciences accounts. David brings 22 years of industry and institutional sales experience to the Firm and joins from Goldman Sachs, where he covered buy side institutions. Prior to Goldman Sachs, David spent eight years with Deutsche Bank as the firm’s Healthcare Sector Sales Specialist. Eric Ritter, Frank Hourigan and David Newcomb will be based in New York and will report to Greg Giannakopoulos, Head of Institutional Sales. Joseph Radic recently joined the Firm as a Managing Director in Trading. Joe brings over 20 years of trading experience to the Firm, including the last 13 years at Sanford C. Bernstein & Co., where he most recently led the firm’s small cap trading effort. Albert Aguiar recently joined the firm as a Managing Director in Sales Trading and will be the Small Cap Specialist. Albert brings 20 years of industry experience to the Firm and joins from Sanford C. Bernstein & Co. Prior to Sanford Bernstein, Albert was responsible for developing the Small Cap sales platforms at both Nomura Securities and UBS and helped launch the Small Cap Desk at Merrill Lynch. Carolyn Horn joined the Firm in October 2015 as a Vice President in Healthcare Capital Markets. Carolyn will play a key role in expanding the Firm’s footprint in the Healthcare market, working closely with both the Firm’s corporate clients and with the Firm’s Investment Banking and equities professionals across the Equity Research, Institutional Sales and Trading groups. Previously, Carolyn was a Healthcare Specialist at JMP Securities and spent several years at the Biotechnology Industry Organization in Washington DC, where she led Investor Relations and Business Development.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|